RE: Ellison institute background. What an opportunity for Sath fresh after fast track with the FDA4 Jun 2026 17:00
Apologies if this has been mentioned before but Sath moving at this stage could simply be a ‘no brainier’ as far as he was concerned. Perhaps he saw a buy out of Scancell looming , which would result in him being surplus to requirements, and thought the FO position at Ellison Institute would be a great move for him, at a great time, plus he still has a significant nos of shares in Scancell…..win, win situation!